AHA decries site neutral payments in Lower Cost More Transparency Act

The House passed H.R. 5378, a bill aimed at transparency in hospital pricing that also addresses PBM spread pricing.

Susan Morse, Executive Editor – December 12, 2023 –

The U.S. House of Representatives has passed H.R. 5378, the Lower Costs, More Transparency Act, a bill aimed at mandating greater hospital price transparency that would curb pharmacy benefit manager spread pricing.

The bill passed the House by a vote of 320 to 71 and now heads to the Senate for consideration. Congress is scheduled to recess for the year at the end of this week.

It also provides price transparency for clinical lab tests so that patients will get more clarity into the prices they’ll pay for these tests.

The bill spares hospitals $16 billion in cuts to disproportionate share hospital payments for two years.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button